Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Redox-active metal ions are metal ions capable of undergoing reversible changes in their oxidation state, enabling them to participate in electron transfer reactions. Key examples include Copper (Cu(I/II)) and Iron (Fe(II/III)). They serve as essential cofactors for enzymes involved in various biological processes, including oxidative metabolism and neurotransmitter synthesis. Dysregulation of redox-active metal ion homeostasis can lead to the overproduction of reactive oxygen species (ROS) and oxidative stress, contributing to neurodegenerative diseases. Therapeutic strategies involve the use of chelators to bind excess free metal ions, restoring homeostasis and mitigating oxidative damage.
Chelation of excess metal ions to restore homeostasis and reduce oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Redox-active Metal Ions.